Download presentation
1
Indometacin-Responsive Headaches
Manjit S Matharu Headache Group, Institute of Neurology & The National Hospital for Neurology and Neurosurgery London UK HULL-BASH Headache Meeting 20th January 2011
2
Indometacin-Responsive Headaches
ABSOLUTE RESPONSE Paroxysmal Hemicrania Hemicrania Continua PARTIAL RESPONSE Primary stabbing headache Valsalva-induced headache Primary cough headache Primary exertional headache Primary sex headache Hypnic headache
3
Indometacin Introduced in clinical practice in 1963
Non-steroidal anti-inflammatory drug (NSAID) Anti-inflammatory, anti-pyretic and analgesic effects MECHANISM OF ACTION IN INDOMETACIN-RESPONSIVE HEADACHES Basis of specific action unknown: Inhibits cyclooxygenase 1 and cyclooxygenase 2 (therefore, the generation of prostaglandins) and leukocyte activity Decreases both cerebral blood flow and CSF pressure Indometacin also affects melatonin secretion Indometacin may have an effect on nitrinergic mechanisms (David Dodick, 1998)
4
Indometacin-Responsive Headaches
ABSOLUTE RESPONSE Paroxysmal Hemicrania Hemicrania Continua PARTIAL RESPONSE Primary stabbing headache Valsalva-induced headache Primary cough headache Primary exertional headache Primary sex headache Hypnic headache
5
Trigeminal Autonomic Cephalalgias
Cluster Headache Paroxysmal Hemicrania SUNCT (Short-lasting Unilateral Neuralgiform headache with Conjunctival injection and Tearing) Unilateral head pain, predominantly V1 Very severe / Excruciating Cranial autonomic symptoms Parasympathetic h Sympathetic i Attack frequency and duration differs Treatment responses differ
6
Paroxysmal Hemicrania IHS CLASSIFICATION CRITERIA
Severe Unilateral Orbital, supraorbital or temporal pain 2-30 minutes duration >5 attacks daily at least 50% of the time Associated symptoms: -Conjunctival injection -Lacrimation -Ptosis -Miosis -Eyelid oedema -Nasal congestion -Rhinorrhea -Forehead and facial sweating Stopped completely by indometacin
7
Trigeminal Autonomic Cephalalgias
Cluster Headache Paroxysmal Hemicrania SUNCT Lifetime prevalence 1/1000 1/50,000* 1/15,000 F:M ratio 1: 1:1 1:1.5 Age Mean Range 30 6-67 37 5-68 48 19-75
8
Trigeminal Autonomic Cephalalgias
Cluster Headache Paroxysmal Hemicrania SUNCT Attack frequency (daily) 1-8 1-40 3-200 Duration of attack 15-180mins 2-30mins 5-240secs Pain quality Sharp, throbbing Stabbing, burning Pain intensity Very severe Circadian periodicity 70% 45% Absent
9
Trigeminal Autonomic Cephalalgias
Cluster Headache Paroxysmal Hemicrania SUNCT Autonomic features +++ +++* Migrainous features ++ + Restless or agitated 90% 80% 65% Aura 14% Rare Triggers Alcohol Cutaneous - Episodic : Chronic 90:10 35:65 10:90
10
Paroxysmal Hemicrania
Trigeminal Autonomic Cephalalgias EVIDENCE FOR HYPOTHALAMIC DYSFUNCTION Cluster Headache PET Study Paroxysmal Hemicrania PET Study SUNCT fMRI Study May et al, Lancet 1998 Matharu et al, Ann Neurol 2004 May et al, Ann Neurol 1999 Posterior hypothalamic region activation in all trigeminal autonomic cephalalgias
11
Paroxysmal Hemicrania PET STUDY
Posterior Hypothalamus Ventral Midbrain Matharu et al, Ann Neurol 2006
12
Adapted from Antonaci et al. Headache 1998;38:122-8
Indometacin Trial Oral Indometacin trial 25mgs tds for 3 days 50mgs tds for 3 days 75mgs tds for 7 days Indotest (Intramuscular indometacin) hr Time Indomethacin 100mgs intramuscularly Adapted from Antonaci et al. Headache 1998;38:122-8
13
Paroxysmal Hemicrania vs. Cluster Headache
FEATURE CH PH Duration (min) 2 – 30 Frequency (attacks/day) 1- 8 1 - 40 Indometacin - + Trial of Indometacin if: Attack frequency > 5 daily Attack duration < 30 minutes Chronic subtypes Medically intractable
14
Trigeminal Autonomic Cephalalgias INVESTIGATIONS
Cittadini and Matharu, Neurologist 2009 Literature review of symptomatic TACs published between Identified 37 symptomatic cases of TACs (CH 24, PH 3, SUNCT 10) Pituitary tumours: CH 7, PH 3, SUNCT 7 Levy et al, Brain 2005 84 pituitary tumour patients with headaches Studied in TERTIARY REFERRAL NEUROSURGICAL CENTRE 4% had CH; 5% had SUNCT (76% had migraine) Investigate all TAC patients for pituitary tumours? Prevalence of pituitary tumours in TACs is unknown 1 in 10 of the population have an incidental pituitary micro-adenoma (< 1cm diameter) on MRI pituitary 1 in 500 have a macro-adenoma
15
Paroxysmal Hemicrania TREATMENTS
Indometacin Persistence of efficacy; investigate if efficacy wears off 23% develop GI side effects with chronic treatment Other NSAIDs COX-II inhibitors Topiramate Verapamil Greater occipital nerve blocks Neuromodulation Occipital nerve stimulation Posterior hypothalamic region (midbrain tegmentum) DBS
16
Hemicrania Continua IHS DIAGNOSTIC CRITERIA
Headache for >3 months B. All of the following characteristics: 1. unilateral pain without side-shift 2. daily and continuous, without pain-free periods 3. moderate intensity, but with exacerbations of severe pain C. At least one of the following autonomic features occurs during exacerbations and ipsilateral to the side of pain: 1. conjunctival injection and/or lacrimation 2. nasal congestion and/or rhinorrhoea 3. ptosis and/or miosis D. Complete response to therapeutic doses of indomethacin
17
Hemicrania Continua TREATMENTS
Indometacin (25-300mgs) Other NSAIDs Piroxicam, Naproxen, Ibuprofen, Aspirin COX II Inhibitors Topiramate Gabapentin Verapamil Occipital nerve stimulation
18
Hemicrania Continua OCCIPITAL NERVE STIMULATION
Burns B, Watkins L, Goadsby PJ. Lancet Neurol 2008 Results 5/6 (83%) reported meaningful benefit Benefit built up over 2 days -3 months Worsened rapidly when stimulator off Degree of Improvement % Number Substantial 80-95% 4 Moderate 30% 1 Worse* -20% * Patient has migraine not hemicrania continua
19
Hemicrania Continua PET STUDY
Posterior Hypothalamus Dorsal Rostral Pons Ventrolateral Midbrain Matharu et al, Headache 2004
20
Primary Stabbing Pain Not especially rare – 3% of general population, 42% of migraineurs. Also commoner in cluster, HC, TTH Stabbing or jabbing pain Ophthalmic trigeminal distribution Last a few seconds (rarely up to 1 minute) May be unifocal or move around the head Occurs at irregular intervals Important to differentiate from: Trigeminal Neuralgia: TN is triggerable, Vii /Viii SUNCT – longer runs of stabbing pain, cranial autonomic symptoms Treatment (if required): Indometacin Celecoxib Melatonin Gabapentin
21
Primary Cough Headache
4/19/ :37 AM Primary Cough Headache Previously known as benign cough headache, Valsalva headache Sudden headache triggered (not worsened) by coughing/Valsalva Lasts 1 second-30mins Associated features uncommon Approx 40% of cough headache is secondary, usually due to Chiari malformation Essential to exclude structural lesions, especially in posterior fossa Mean age of onset 67 (range in one series) Treatment: Indometacin Acetazolamide, Methysergide Lumbar puncture – can be curative, may need repeating © 2007 Microsoft Corporation. All rights reserved. Microsoft, Windows, Windows Vista and other product names are or may be registered trademarks and/or trademarks in the U.S. and/or other countries. The information herein is for informational purposes only and represents the current view of Microsoft Corporation as of the date of this presentation. Because Microsoft must respond to changing market conditions, it should not be interpreted to be a commitment on the part of Microsoft, and Microsoft cannot guarantee the accuracy of any information provided after the date of this presentation. MICROSOFT MAKES NO WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, AS TO THE INFORMATION IN THIS PRESENTATION.
22
Primary Exertional Headache
4/19/ :37 AM Primary Exertional Headache IHS criteria: Pulsating headache Lasting from 5 minutes to 48 hours Brought on by and occurring only during or after physical exertion Not attributed to another disorder On first occurrence, essential to exclude SAH/dissection Treatment: Indomethacin Propranolol Ergotamine (pre-emptive) Flunarizine © 2007 Microsoft Corporation. All rights reserved. Microsoft, Windows, Windows Vista and other product names are or may be registered trademarks and/or trademarks in the U.S. and/or other countries. The information herein is for informational purposes only and represents the current view of Microsoft Corporation as of the date of this presentation. Because Microsoft must respond to changing market conditions, it should not be interpreted to be a commitment on the part of Microsoft, and Microsoft cannot guarantee the accuracy of any information provided after the date of this presentation. MICROSOFT MAKES NO WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, AS TO THE INFORMATION IN THIS PRESENTATION.
23
Primary Headache associated with Sexual Activity
4/19/ :37 AM Primary Headache associated with Sexual Activity Preorgasmic Headache: Dull ache in the head and neck associated with awareness of neck and/or jaw muscle contraction Occurs during sexual activity and increases with sexual excitement Orgasmic Headache: Sudden severe ("explosive") headache occurring at orgasm On first occurrence, essential to exclude SAH/dissection Treatment: Pre-emptive or prophylactic Indometacin Propranolol/Metoprolol Diltiazem Naratriptan 2.5mg © 2007 Microsoft Corporation. All rights reserved. Microsoft, Windows, Windows Vista and other product names are or may be registered trademarks and/or trademarks in the U.S. and/or other countries. The information herein is for informational purposes only and represents the current view of Microsoft Corporation as of the date of this presentation. Because Microsoft must respond to changing market conditions, it should not be interpreted to be a commitment on the part of Microsoft, and Microsoft cannot guarantee the accuracy of any information provided after the date of this presentation. MICROSOFT MAKES NO WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, AS TO THE INFORMATION IN THIS PRESENTATION.
24
Hypnic Headache IHS DIAGNOSTIC CRITERIA TREATMENTS Dull headache
4/19/ :37 AM Hypnic Headache IHS DIAGNOSTIC CRITERIA Dull headache Develops only during sleep, and awakens patient At least two of the following characteristics: occurs >15 times per month lasts ≥15 minutes after waking first occurs after age of 50 years No autonomic symptoms and no more than one of nausea, photophobia or phonophobia TREATMENTS Caffeine, Indometacin, Lithium, Flunarizine © 2007 Microsoft Corporation. All rights reserved. Microsoft, Windows, Windows Vista and other product names are or may be registered trademarks and/or trademarks in the U.S. and/or other countries. The information herein is for informational purposes only and represents the current view of Microsoft Corporation as of the date of this presentation. Because Microsoft must respond to changing market conditions, it should not be interpreted to be a commitment on the part of Microsoft, and Microsoft cannot guarantee the accuracy of any information provided after the date of this presentation. MICROSOFT MAKES NO WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, AS TO THE INFORMATION IN THIS PRESENTATION.
25
Indometacin-Responsive Headaches
Rare but important group of headache syndromes to recognize in view of therapeutic response to Indometacin Consider trial of Indometacin in: Strictly unilateral paroxysmal or continuous headaches Short-lasting unilateral or bilateral headaches
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.